In its report “HER2-Positive Breast Cancer – Epidemiolog Analysis and Forecast to 2033,” the data analysis firm has estimated ...

Jeffrey Kindler, CEO, Centrexion Therapeutics, and Alfonso Zulueta, Non-Executive Chairman, Interpharma Investments Limited, ...

M Srinivas, the AIIMS has taken the decision that is in line witn the institute's aims to streamline transactions, enhance ...

In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after ...

Dr Pananchukunnath interacted with ETPharma on how peptides and oligonucleotides are a different class of compounds, how they ...

Bengaluru: Business Wire India Cancer. The word itself evokes fear and endless struggle with treatments. But what if there ...

Dr Chander interacted with ETPharma and discussed what NIB is doing currently and how they intend to scale advanced and ...

The team found that close to 30 per cent of the eligible children have received only one measles-containing vaccine (MCV1), ...

The drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in patients with high-risk endometrial ...

Mumbai: Prashant Mehta, Permanent Trustee, Lilavati Hospital and Research Centre interacted with ETHealthworld's Prabhat ...

Indian generic drugmakers like Dr. Reddy's Laboratories, Cipla and Sun Pharmaceutical have been benefitting from price ...

Eleven of the samples showed an alarming presence of antimicrobial resistance genes (ARG) against 15 important antibiotics, ...